Zou L - Search Results

1

Expression features of SOX9 associate with tumor progression and poor prognosis of hepatocellular carcinoma.

Guo X, Xiong L, Sun T, Peng R, Zou L, Zhu H, Zhang J, Li H, Zhao J. Guo X, et al. Among authors: zou l. Diagn Pathol. 2012 Apr 19;7:44. doi: 10.1186/1746-1596-7-44. Diagn Pathol. 2012. PMID: 22515642 Free PMC article.

2

Upregulation of bone morphogenetic protein 4 is associated with poor prognosis in patients with hepatocellular carcinoma.

Guo X, Xiong L, Zou L, Zhao J. Guo X, et al. Among authors: zou l. Pathol Oncol Res. 2012 Jul;18(3):635-40. doi: 10.1007/s12253-011-9488-2. Epub 2012 Feb 15. Pathol Oncol Res. 2012. PMID: 22350792 Free article.

3

L1 cell adhesion molecule overexpression in hepatocellular carcinoma associates with advanced tumor progression and poor patient survival.

Guo X, Xiong L, Zou L, Sun T, Zhang J, Li H, Peng R, Zhao J. Guo X, et al. Among authors: zou l. Diagn Pathol. 2012 Aug 13;7:96. doi: 10.1186/1746-1596-7-96. Diagn Pathol. 2012. PMID: 22888955 Free PMC article.

4

MicroRNA-101 suppresses SOX9-dependent tumorigenicity and promotes favorable prognosis of human hepatocellular carcinoma.

Zhang Y, Guo X, Xiong L, Kong X, Xu Y, Liu C, Zou L, Li Z, Zhao J, Lin N. Zhang Y, et al. Among authors: zou l. FEBS Lett. 2012 Dec 14;586(24):4362-70. doi: 10.1016/j.febslet.2012.10.053. Epub 2012 Nov 21. FEBS Lett. 2012. PMID: 23178713 Free article.

5

Decreased expression of SOX6 confers a poor prognosis in hepatocellular carcinoma.

Guo X, Yang M, Gu H, Zhao J, Zou L. Guo X, et al. Among authors: zou l. Cancer Epidemiol. 2013 Oct;37(5):732-6. doi: 10.1016/j.canep.2013.05.002. Epub 2013 Jun 1. Cancer Epidemiol. 2013. PMID: 23731550

6

Upregulation of microRNA-372 associates with tumor progression and prognosis in hepatocellular carcinoma.

Gu H, Guo X, Zou L, Zhu H, Zhang J. Gu H, et al. Among authors: zou l. Mol Cell Biochem. 2013 Mar;375(1-2):23-30. doi: 10.1007/s11010-012-1521-6. Epub 2013 Jan 6. Mol Cell Biochem. 2013. PMID: 23291979

7

Foxo3a expression is a prognostic marker in breast cancer.

Jiang Y, Zou L, Lu WQ, Zhang Y, Shen AG. Jiang Y, et al. Among authors: zou l. PLoS One. 2013 Aug 13;8(8):e70746. doi: 10.1371/journal.pone.0070746. eCollection 2013. PLoS One. 2013. PMID: 23967095 Free PMC article.

8

Expression of CRM1 in human gliomas and its significance in p27 expression and clinical prognosis.

Shen A, Wang Y, Zhao Y, Zou L, Sun L, Cheng C. Shen A, et al. Among authors: zou l. Neurosurgery. 2009 Jul;65(1):153-9; discussion 159-60. doi: 10.1227/01.NEU.0000348550.47441.4B. Neurosurgery. 2009. PMID: 19574837

9

Overexpression of forkhead box J2 can decrease the migration of breast cancer cells.

Wang Y, Yang S, Ni Q, He S, Zhao Y, Yuan Q, Li C, Chen H, Zhang L, Zou L, Shen A, Cheng C. Wang Y, et al. Among authors: zou l. J Cell Biochem. 2012 Aug;113(8):2729-37. doi: 10.1002/jcb.24146. J Cell Biochem. 2012. PMID: 22441887

10

Overexpression of PPARγ can down-regulate Skp2 expression in MDA-MB-231 breast tumor cells.

Meng J, Ding Y, Shen A, Yan M, He F, Ji H, Zou L, Liu Y, Wang Y, Lu X, Wang H. Meng J, et al. Among authors: zou l. Mol Cell Biochem. 2010 Dec;345(1-2):171-80. doi: 10.1007/s11010-010-0570-y. Epub 2010 Aug 24. Mol Cell Biochem. 2010. PMID: 20734220

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,115 results

Search Page

Filters